A detailed history of Moody National Bank Trust Division transactions in Novo Nordisk A S stock. As of the latest transaction made, Moody National Bank Trust Division holds 1,583 shares of NVO stock, worth $191,163. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,583
Holding current value
$191,163
% of portfolio
0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 03, 2024

BUY
$122.71 - $146.91 $194,249 - $232,558
1,583 New
1,583 $225,000
Q2 2022

Jul 07, 2022

SELL
$103.24 - $121.81 $619,440 - $730,860
-6,000 Reduced 74.01%
2,107 $234,000
Q4 2021

Jan 13, 2022

SELL
$95.88 - $117.08 $4.79 Million - $5.85 Million
-50,000 Reduced 86.05%
8,107 $908,000
Q3 2021

Oct 07, 2021

BUY
$84.42 - $106.62 $1,013 - $1,279
12 Added 0.02%
58,107 $5.58 Million
Q4 2020

Mar 04, 2021

SELL
$63.89 - $73.8 $22,744 - $26,272
-356 Reduced 0.61%
58,095 $4.06 Million
Q3 2020

Oct 08, 2020

SELL
$63.69 - $70.22 $77,638 - $85,598
-1,219 Reduced 2.04%
58,451 $4.06 Million
Q2 2020

Jul 10, 2020

BUY
$58.54 - $67.94 $22,011 - $25,545
376 Added 0.63%
59,670 $3.91 Million
Q1 2020

Apr 17, 2020

BUY
$49.46 - $64.78 $5,638 - $7,384
114 Added 0.19%
59,294 $3.57 Million
Q4 2019

Jan 28, 2020

BUY
$49.86 - $58.26 $8,575 - $10,020
172 Added 0.29%
59,180 $3.43 Million
Q3 2019

Oct 18, 2019

BUY
$47.54 - $53.43 $21,488 - $24,150
452 Added 0.77%
59,008 $3.05 Million
Q2 2019

Jul 22, 2019

BUY
$46.79 - $52.47 $4,772 - $5,351
102 Added 0.17%
58,556 $2.99 Million
Q1 2019

Apr 11, 2019

BUY
$46.36 - $52.63 $5,887 - $6,684
127 Added 0.22%
58,454 $3.06 Million
Q4 2018

Jan 07, 2019

BUY
$41.54 - $47.25 $96,663 - $109,950
2,327 Added 4.16%
58,327 $2.69 Million
Q3 2018

Oct 31, 2018

BUY
$46.76 - $51.24 $2.62 Million - $2.87 Million
56,000 New
56,000 $2.64 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Moody National Bank Trust Division Portfolio

Follow Moody National Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Moody National Bank Trust Division with notifications on news.